This site is intended for healthcare professionals
News

Pfizer Inc. + BioNTech SE announced that the first participants have been dosed in a global phase II/III study to evaluate the Pfizer-BioNTech COVID-19 vaccine in preventing COVID-19 in pregnant women 18 years of age and older .

Read time: 1 mins
Last updated:28th Jun 2021
Published:25th Feb 2021
Condition: Coronavirus/COVID-19 Infection
Type: drug
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest